Trials / Completed
CompletedNCT00866203
HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy
A Prospective, Randomized, Multicenter Trial Comparing a Modified HDS Therapy Supported by PBPC Transplant With Additional 4 Courses of Front-Line Therapy in Adult Aggressive NHL With PR After Short Course of Up-Front Chemotherapy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 441 (actual)
- Sponsor
- Gruppo Italiano Studio Linfomi · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study is planned to compare the outcome of aggressive NHL patients in partial remission after four courses of front-line therapy, randomly assigned to receive either additional four courses of the same regimen or a modified HDS program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HDS vs ProMECE/CytaBOM |
Timeline
- Start date
- 2000-10-01
- Completion
- 2008-04-01
- First posted
- 2009-03-20
- Last updated
- 2009-03-20
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00866203. Inclusion in this directory is not an endorsement.